Education
About Us
Working with TipRanks
Follow Us
Novabay Pharmaceuticals (NBY)
:NBY
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.73M | $ 14.40M | $ 8.42M | $ 9.93M | $ 6.60M |
| Gross Profit | $ 7.89M | $ 7.78M | $ 5.64M | $ 5.96M | $ 4.86M |
| Operating Income | $ -5.00M | $ -7.68M | $ -8.86M | $ -6.43M | $ -9.40M |
| EBITDA | $ -4.80M | $ -7.20M | $ -8.74M | $ -6.38M | $ -9.34M |
| Net Income | $ -9.64M | $ -16.27M | $ -6.56M | $ -11.04M | $ -10.49M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.13M | $ 5.36M | $ 7.50M | $ 11.95M | $ 6.94M |
| Total Assets | $ 9.03M | $ 16.40M | $ 23.98M | $ 15.24M | $ 11.22M |
| Total Debt | $ 2.74M | $ 2.04M | $ 551.00K | $ 503.00K | $ 4.05M |
| Net Debt | $ -390.00K | $ -3.32M | $ -6.95M | $ -11.45M | $ -2.89M |
| Total Liabilities | $ 5.72M | $ 5.84M | $ 13.81M | $ 2.92M | $ 10.25M |
| Stockholders' Equity | $ 3.31M | $ 10.55M | $ 10.17M | $ 12.32M | $ 973.00K |
| Cash Flow | |||||
| Free Cash Flow | $ -4.15M | $ -6.77M | $ -9.24M | $ -4.75M | $ -7.95M |
| Operating Cash Flow | $ -4.13M | $ -6.65M | $ -9.19M | $ -4.72M | $ -7.93M |
| Investing Cash Flow | $ -19.00K | $ -112.00K | $ -12.04M | $ -26.00K | $ -19.00K |
| Financing Cash Flow | $ 1.91M | $ 4.63M | $ 16.79M | $ 9.76M | $ 11.70M |